Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
5 pending office actions • 2 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Dyno Therapeutics Inc. has 5 pending office actions within the Biotechnology & Pharmaceuticals technology area. These cases are located in 2 distinct art units, suggesting a focused set of technical challenges for their current patent applications. The company is working with 4 distinct examiners on these 5 actions, which provides a relatively high degree of examiner variety for such a small number of pending matters.
SALVOZA, M FRANCO G is the busiest examiner for this portfolio, currently overseeing 2 pending office actions. This examiner is responsible for 2 of the 5 total actions, making their specific feedback and examination style highly influential for the company's current goals. The remaining actions are split among other distinct examiners, meaning that most of the company's active cases are being handled by different individuals.
The concentration of 5 pending office actions within 2 distinct art units indicates that the company's work is technically specialized within Biotechnology & Pharmaceuticals. However, the use of 4 distinct examiners means that the company must still prepare for different interpretive approaches. With SALVOZA, M FRANCO G handling a portion of the actions, the prosecution team can focus on building a consistent dialogue with this examiner while also addressing the unique requirements of the other examiners.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §102 only | 1 (20%) |
| §112 only | 1 (20%) |
| Double-patenting only | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SALVOZA, M FRANCO G | 2 | 68.4% | +30.0% |
| MONTANARI, DAVID A | 1 | 64.7% | +49.0% |
| CHESTNUT, BARRY A | 1 | 73.5% | +6.4% |
| CORNELIUS, CLAIRE ADRIENNE | 1 | 66.7% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18571367 | CAPSID VARIANTS AND METHODS OF USING THE SAME | CORNELIUS, CLAIRE ADRIENNE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19537081 | CAPSID POLYPEPTIDES AND METHODS OF USE THEREOF | MONTANARI, DAVID A | — |
| 18779855 | CAPSID VARIANTS AND METHODS OF USING THE SAME | SALVOZA, M FRANCO G | — |
| 18761730 | CAPSID VARIANTS AND METHODS OF USING THE SAME | SALVOZA, M FRANCO G | — |
| Art Unit | Apps |
|---|---|
| 1672 | 2 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19537081 | CAPSID POLYPEPTIDES AND METHODS OF USE THEREOF | MONTANARI, DAVID A | 1632 | §112 | Final Rejection | — | Pending | Feb 11, 2026 |
| 18779855 | CAPSID VARIANTS AND METHODS OF USING THE SAME | SALVOZA, M FRANCO G | — | DP | Non-Final OA | — | Pending | Jul 22, 2024 |
| 18761730 | CAPSID VARIANTS AND METHODS OF USING THE SAME | SALVOZA, M FRANCO G | — | DP | Non-Final OA | — | Pending | Jul 02, 2024 |
| 18573582 | CAPSID VARIANTS AND METHODS OF USING THE SAME | CHESTNUT, BARRY A | 1672 | §102 | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18571367 | CAPSID VARIANTS AND METHODS OF USING THE SAME | CORNELIUS, CLAIRE ADRIENNE | 1672 | §101§112 | Final Rejection | — | Pending | Dec 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial